Key result
Higher septal LGE is linked to ~14% higher risk of adverse LBBAP response per 1%.
Why the study?
Interventricular septal fibrosis is linked to left bundle branch area pacing efficacy in heart failure patients with LBBB, prompting evaluation of the association between IVS late gadolinium enhancement percentage and pacing response in non-ischemic cardiomyopathy with LBBB.
Does interventricular septal late gadolinium enhancement percentage predict left bundle branch area pacing response trajectories in non-ischemic cardiomyopathy patients with complete left bundle branch block?
Observational (n=113)
Yes
Does interventricular septal late gadolinium enhancement percentage predict left bundle branch area pacing response trajectories in non-ischemic cardiomyopathy patients with complete left bundle branch block?
Interventricular septal fibrosis measured by cardiac MRI late gadolinium enhancement independently predicts echocardiographic response trajectories to left bundle branch area pacing in patients with non-ischemic cardiomyopathy and complete LBBB.
Answers are grounded in this paper and cite their sources.
Septal LGE% may flag NICM patients at risk for poor LBBAP response trajectories; leaves open prospective validation before guiding selection.
BACKGROUND: Left bundle branch area pacing (LBBAP) is an alternative strategy for heart failure (HF) patients with left bundle branch block (LBBB). Interventricular septal (IVS) fibrosis is linked to LBBAP efficacy. OBJECTIVE: To investigate the association between IVS late gadolinium enhancement percentage (IVS LGE%) and LBBAP response in non-ischemic cardiomyopathy (NICM) patients with LBBB. METHODS: This was a two-center prospective observational study. Patients with NICM and complete LBBB were consecutively enrolled and received LBBAP from January 2021 to December 2024. Patients were divided into early, delayed, and non-response groups based on absolute left ventricular ejection fraction (LVEF) improvement ≥5% at 6 and 12 months. RESULTS: A total of 113 patients were included, with 86 (76.1%) early responders, 13 (11.5%) delayed responders, and 14 (12.4%) non-responders. IVS LGE% linearly increased the risk of non-early response, with each 1% increase conferring a 14% higher risk of adverse response progression (early to delayed or non-response) (adjusted OR=1.14, 95%CI 1.05-1.23; P=0.002). 75.3% of IVS fibrosis-related 6-month impairment was mediated by failed LBB captured (direct effect P=0.204), while the direct inhibitory effect of IVS fibrosis emerged at 12 months (mediation proportion 60.8%, β=-0.33, P=0.005). Optimal IVS LGE% cut-off values were 7.62% for early response and 12.33% for delayed response, with 12-month response rates of 95.06%, 93.75% and 43.75% across low, intermediate and high IVS LGE% groups, respectively. CONCLUSION: IVS fibrosis independently predicts LBBAP response and prognosis in NICM patients with complete LBBB, and modulates LBBAP efficacy through a time-dependent biphasic mechanism.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) conducted an observational in Non-ischemic cardiomyopathy (NICM) with complete left bundle branch block (LBBB) (n=113). Interventricular septal late gadolinium enhancement percentage (IVS LGE%) vs. Lower IVS LGE% (low, intermediate, and high IVS LGE% groups) was evaluated on Adverse LBBAP response progression (early to delayed or non-response, defined by absolute LVEF improvement >=5% at 6 and 12 months) (OR 1.14, 95% CI 1.05-1.23, p=0.002). Each 1% increase in interventricular septal LGE% increased the risk of adverse LBBAP response progression in NICM patients with LBBB.
Synapse has enriched 10 related papers. Consider them for comparative context: